LGND
#1272
Ligand Pharmaceuticals Incorporated - Common Stock
284.5 2 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.16%
Monthly Change
-3.43%
6 month change
+44.28%
Year Change
+52.05%
Previous Close
287.8 5
Open
284.5 2
Low
284.5 2
High
284.5 2
Volume
55
Financials
- Market Capitalization 5.67 B
- Employee 47
- Founded N/A
- CEO N/A
- Website www.ligand.com
- Headquarter Delaware, United States
- FIGI BBG000BKF014
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
30.84
Price to sales ratio
14.31
Dividends per share
2.5
Dividend yield %
1.32
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1245 |  DFTX Definium Therapeutics, Inc. - Common Shares | 43.82 USD | +0.11% | -4.51% | +4.33% | +190.01% | 5.89 B USD | ||
| 1261 |  CRSP CRISPR Therapeutics AG - Common Shares | 59.37 USD | +0.24% | -0.59% | +25.20% | +12.08% | 5.74 B USD | ||
| 1341 |  ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 29.73 USD | +0.51% | +2.24% | +13.82% | +13.52% | 5.12 B USD | ||
| 1374 |  DYN Dyne Therapeutics, Inc. - Common Stock | 26.09 USD | -1.02% | -0.50% | +0.50% | +11.45% | 4.87 B USD |
Frequently asked questions about Ligand Pharmaceuticals Inc.
What is the Ligand Pharmaceuticals Inc. stock price today?
The current price of Ligand Pharmaceuticals Inc. (LGND) is 284.52. Over the past 24 hours, the stock has changed by -1.16%. Follow the LGND chart for real-time price dynamics.
What is the stock ticker of Ligand Pharmaceuticals Inc.?
Ligand Pharmaceuticals Inc. trades under the ticker LGND. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Ligand Pharmaceuticals Inc. stock going up?
LGND has changed by -1.24% over the last week, -3.43% over the last month, and +52.05% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Ligand Pharmaceuticals Inc.?
Ligand Pharmaceuticals Inc. currently has a market capitalization of 5.67 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
Does Ligand Pharmaceuticals Inc. release financial reports?
Yes. You can track Ligand Pharmaceuticals Inc. financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What were Ligand Pharmaceuticals Inc. earnings last quarter?
Last quarter, Ligand Pharmaceuticals Inc. reported earnings of 2.42 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Ligand Pharmaceuticals Inc. revenue for the last quarter?
Ligand Pharmaceuticals Inc. reported quarterly revenue of 63.69 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Ligand Pharmaceuticals Inc. net income for the last quarter?
Ligand Pharmaceuticals Inc. reported net income of 48.51 M for the last quarter. The previous quarter showed -13.35 M, which means net income changed by +463.49%.
How many employees does Ligand Pharmaceuticals Inc. have?
As of the latest available data, Ligand Pharmaceuticals Inc. has 47 employees. Workforce size can provide additional context about the company's scale and operations.
What is Ligand Pharmaceuticals Inc. EBITDA?
Ligand Pharmaceuticals Inc. EBITDA is -23.63 M, and its EBITDA margin is -37.1%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Ligand Pharmaceuticals Inc. stock?
You can buy Ligand Pharmaceuticals Inc. (LGND) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Ligand Pharmaceuticals Inc. stock?
Investing in Ligand Pharmaceuticals Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the LGND chart and related analysis on metatrader.com as part of your research.